BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10448314)

  • 1. Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead.
    Osterode W; Barnas U; Geissler K
    Occup Environ Med; 1999 Feb; 56(2):106-9. PubMed ID: 10448314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hemin enhancement of burst-forming units-erythroid clonal efficiency by progenitor cells from normal and HIV-infected patients.
    Abraham NG; Mathew A; Jiang S; Lutton JD; Nishimura M; Chertkov JL; Levere RD
    Acta Haematol; 1991; 86(4):189-93. PubMed ID: 1805486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells.
    Zheng B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anemia of end-stage renal disease: hematopoietic progenitor cell response.
    Segal GM; Eschbach JW; Egrie JC; Stueve T; Adamson JW
    Kidney Int; 1988 May; 33(5):983-8. PubMed ID: 3392887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal.
    Lee HY; Gao X; Barrasa MI; Li H; Elmes RR; Peters LL; Lodish HF
    Nature; 2015 Jun; 522(7557):474-7. PubMed ID: 25970251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure.
    Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC
    Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid progenitors in polycythemia vera demonstrate a different response pattern to IL-4 compared to the normal BFU-E from peripheral blood.
    de Wolf JT; Hendriks DW; Beentjes JA; Esselink MT; Smit JW; Halie MR; Vellenga E
    Exp Hematol; 1991 Oct; 19(9):888-92. PubMed ID: 1893965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood hematopoietic progenitor cells in beta-thalassemia major.
    Chen JS; Lin KH; Tsao CJ
    Int J Cell Cloning; 1992 Nov; 10(6):338-43. PubMed ID: 1460323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin.
    Göbel V; Hoffmann HG; Müller-Wiefel DE; Braun A; Ludwig R; Schärer K; Debatin KM
    Eur J Pediatr; 1994 Jan; 153(1):43-8. PubMed ID: 8313924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
    Chow FP; Sutton PA; Hamburger AW
    Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.